Search results
Results from the WOW.Com Content Network
Following her post-doctoral training, Hur joined the faculty at Harvard Medical School (HMS) in 2008 as an assistant professor and Boston Children's Hospital in 2010. [2] As an assistant professor of biological chemistry and molecular pharmacology, Hur focused her research on how the immune system detects viruses, specifically RNAs. [4]
Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple-negative breast cancer.
Kim Jin-Soo is a chemist, biologist, and entrepreneur. He was CEO and CSO, ToolGen, Inc., is a professor in the Department of Chemistry of Seoul National University and director of the Center for Genome Engineering.
There was a study done “to evaluate the postoperative and survival outcomes of robotic-assisted colorectal cancer surgery in elderly patients”(Cuellar-Gomez et al., 2022), and the data used was with that “of all patients ≥75 years who underwent a robotic-assisted curative resection in Korea University Anam Hospital, Seoul, South Korea ...
In July 2017, SillaJen received approval from the China CFDA to commence phase 3 clinical trial for Pexa-Vec in liver cancer. [ 18 ] In Aug 2017, SillaJen signs a cooperative research and development agreement (CRADA or CRDA) with the National Cancer Institute to conduct a clinical study in combination with Pexa-Vec and AstraZeneca's checkpoint ...
Cardio Tube Interview with Seung-Jung Park, MD from TCTAP 2011 conference in Seoul, Korea (08-11-2011) AMC Int'l News - The 4th Asan Medical Award (06-02-2011) AMC News (04-28-2011): Dr. Seung-Jung Park publishes fourth paper in NEJM; CardioVascular Research Foundation Website; Summitmd.com; CardioVascular Summit-TCTAP; Imaging and Physiology ...
Seung-Yong Seong (born c. 1965) is a South Korean immunologist and microbiologist known for his study of innate immune system response and his development of the damage-associated molecular pattern (DAMP) model of immune response initiation in collaboration with Polly Matzinger. [2]
The IVI headquarters building, located in Seoul National University's Research Park in Seoul, South Korea, was designed by a consortium consisting of Samwoo Architects of South Korea and Payette Associates of Boston, United States. Construction began in 1998 and was completed in 2003.